Concepedia

Publication | Open Access

Farnesoid X receptor agonist INT-767 attenuates liver steatosis and inflammation in rat model of nonalcoholic steatohepatitis

DOIFull Paper Access

54

Citations

25

References

2018

Year

Yingbin Hu, Xinyu Liu, Wei Zhan
Drug Design Development and Therapy

Abstract

INT-767 may be an attractive candidate for a potential novel strategy on the treatment of NASH.

References

YearCitations

Page 1